[HTML][HTML] The usefulness and scientific accuracy of private sector Arabic language patient drug information leaflets
SR Sukkari, AS Al Humaidan, LD Sasich - Saudi Pharmaceutical Journal, 2012 - Elsevier
BACKGROUND: Inadequate access to useful scientifically accurate patient information is a
major cause of the inappropriate use of drugs resulting in serious personal injury and related …
major cause of the inappropriate use of drugs resulting in serious personal injury and related …
[HTML][HTML] Development and evaluation of a required patient safety course
SR Sukkari, LD Sasich, DA Tuttle… - American journal of …, 2008 - ncbi.nlm.nih.gov
Objectives To develop, implement, and assess a required patient safety course for second-year
doctor of pharmacy students. Design A patient safety course was developed that …
doctor of pharmacy students. Design A patient safety course was developed that …
[HTML][HTML] Cisapride and patient information leaflets
SR Sukkari, LD Sasich - CMAJ, 2001 - Can Med Assoc
To measure the quality and usefulness of patient information leaflets distributed in Canadian
pharmacies, we compared the information contained in 3 leaflets distributed in Canada for …
pharmacies, we compared the information contained in 3 leaflets distributed in Canada for …
DIONYSOS study comparing dronedarone with amiodarone
GE Cook, LD Sasich, SR Sukkari - Bmj, 2010 - bmj.com
In their clinical review of the management of atrial fibrillation, Lafuente-Lafuente and colleagues
mention the anticipated release of results comparing dronedarone with amiodarone. 1 …
mention the anticipated release of results comparing dronedarone with amiodarone. 1 …
[HTML][HTML] Unknown risks of pharmacy-compounded drugs
LD Sasich, SR Sukkari - Journal of Osteopathic Medicine, 2008 - degruyter.com
Guillain-Barré syndrome (GBS), also known as acute idiopathic polyneuritis, is a type of
neuromuscular paralysis that has several variants. 1-3 These variants all share similar patterns …
neuromuscular paralysis that has several variants. 1-3 These variants all share similar patterns …
[PDF][PDF] Trials of CCBs
SR Sukkari, LD Sasich - CMAJ, 1998 - Can Med Assoc
In a communication dated July 7, 1997, Bayer Inc. informed Canadian pharmacists and
physicians of the completion of Health Canada’s review of calcium-channel blockers (CCBs). 1 …
physicians of the completion of Health Canada’s review of calcium-channel blockers (CCBs). 1 …
The importance of FDA approval packages and briefing documents in pharmacy education
LD Sasich, SR Sukkari, GE Cook… - American Journal of …, 2009 - ncbi.nlm.nih.gov
To the Editor. A recent article1 by Dr. Jennifer Trujillo described an excellent curriculum
allowing pharmacy students in a third-year elective the ability to develop criticalthinking skills by …
allowing pharmacy students in a third-year elective the ability to develop criticalthinking skills by …
Analysis of metformin treatment for adolescent obesity at 48 rather than 24 weeks after treatment cessation
SR Sukkari, LD Sasich, AS Humaidan… - Archives of pediatrics …, 2010 - jamanetwork.com
Although the Glaser Pediatric Research Net-work Obesity Study Group1 appropriately calls
for more research on the long-term use of metformin, we are concerned that the door …
for more research on the long-term use of metformin, we are concerned that the door …
Weighing benefits and risks of drug to treat obesity
SR Sukkari - CMAJ: Canadian Medical Association Journal, 1997 - ncbi.nlm.nih.gov
I would like to offer a few details that may have been inadvertently omitted by Servier Canada.
As noted in the press release, the study by Abenhaim and associates is an epidemiologic …
As noted in the press release, the study by Abenhaim and associates is an epidemiologic …
[HTML][HTML] Incomplete patient drug information still a problem
SR Sukkari, LD Sasich - CMAJ, 2004 - Can Med Assoc
In 2001, we published a letter criticizing the poor quality of drug information available to the
Canadian public, 1 using as an example cisapride, a drug that had been withdrawn from the …
Canadian public, 1 using as an example cisapride, a drug that had been withdrawn from the …